Front Page Firm Profile People Practice Areas Blog Legal Events Media Contact
From the daily archives: "Thursday, October 13, 2016"

Jonathan Emord, “The FDA’s bow to barbarism” (Washington Times, Oct. 12, 2016)

By Emordadmin On October 13, 2016 · Add Comment
Read Jonathan Emord’s October 12, 2016 article in the Washington Times concerning the FDA’s untenable decision to downgrade Electroconvulsive Therapy (ECT) medical devices from Class III to Class II: The FDA’s bow to barbarism:  Downgrading the brain injury risks from shock therapy is unjustified (Oct. 12, 2016) (opens in new window)
Read Full Article →
  • Categories

    • Advertising
    • Constitutional Law
    • Conventional Foods
    • Cosmetics
    • Dietary Supplements
    • FDA
    • Federal Government
    • FTC
    • Health Claims
    • Import/Export
    • Labeling
    • Legislation
    • Media
    • Medical Devices
    • Medical Foods
    • Medicare/Medicaid
    • New Dietary Ingredients
    • Recommended
    • State Laws
    • Trademarks
    • Uncategorized
  • Archives

    • August 2017
    • October 2016
    • August 2016
    • November 2015
    • October 2015
    • July 2015
    • March 2015
    • February 2015
    • December 2014
    • October 2014
    • September 2014
    • July 2014
    • May 2014
    • April 2014
    • January 2014
    • December 2013
    • November 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • August 2012
    • June 2012
    • December 2011
    • November 2011
    • August 2011
    • July 2011
    • June 2011
    • March 2011
    • June 2010
  • Calendar

    October 2016
    M T W T F S S
    « Aug   Aug »
     12
    3456789
    10111213141516
    17181920212223
    24252627282930
    31  
  • Meta

    • Log in
    • Entries (RSS)
Emord Blog

Pages

  • Sample Page

The Latest

  • PRESS RELEASE: Jonathan Emord Goes Round Two with the FDA on Electroshock Devices
    For Immediate Release:  23 August 2017 Contact:  Dr. Linda Lagemann, Liaison to the […]

More

Thanks for dropping by! Feel free to join the discussion by leaving comments, and stay updated by subscribing to the RSS feed.
© 2012 Emord Legal Blog
Build a website with PageLines